HUTCHMED (HCM) director Daniel Tan submits initial Form 3 filing
Rhea-AI Filing Summary
HUTCHMED (China) Ltd director Daniel Shao Weng Tan filed an initial insider ownership report on Form 3. The filing lists him as a director of the company and does not report any insider buy, sell, acquisition, or disposition transactions at this time.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Who is the reporting person in the HUTCHMED (HCM) Form 3 filing?
The reporting person is Daniel Shao Weng Tan, identified as a director of HUTCHMED (China) Ltd. The Form 3 associates him with the issuer but shows no insider buy, sell, acquire, or dispose transactions in the provided data.
What role does Daniel Shao Weng Tan hold at HUTCHMED (HCM)?
Daniel Shao Weng Tan is listed as a director of HUTCHMED (China) Ltd. The Form 3 data shows the director box checked, while the officer, ten percent owner, and other roles are not marked, indicating his primary relationship is as a board director.
What does the transaction summary indicate in this HUTCHMED (HCM) Form 3?
The transaction summary indicates zero buys, zero sells, and zero acquisitions or dispositions, with net buy/sell shares at zero and direction labeled neutral. This reflects that no reportable transactions are included with this initial insider ownership filing.
Are there any footnote-based ownership clarifications in this HUTCHMED Form 3?
The Form 3 structure includes a footnotes section, but the provided data only shows a null entry. There are no detailed footnote explanations regarding voting power, investment authority, or indirect ownership arrangements visible in the supplied content.